PRTA

4:06 pm Prothena: First Human Dosed in Phase 1 Study of PRX002 for Treatment of Parkinson’s Disease; Entering clinic triggers $15 mln milestone payment from Roche

moreView todays social media effects on PRTAView the latest stocks trending across Twitter. Click to view dashboardSee who Prothena is hiring next, click here to view […]

Prothena to Report Fourth Quarter and Full Year 2013 Financial Results and Host Webcast and Conference Call on March 6

[Thomson Reuters ONE] – Prothena to participate in February investor healthcare conferences, February 24-25 DUBLIN, Ireland, Feb. 18, 2014 (GLOBE NEWSWIRE) — Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology … moreView todays social media effects on PRTAView the latest stocks trending across Twitter. Click to view dashboardSee who Prothena is hiring next, click here to view […]